Interleukin-1 down-regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression
- PMID: 1533388
- PMCID: PMC1384735
Interleukin-1 down-regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression
Abstract
The interleukin-1 receptor type I (IL-1RtI) plays an important role in the biological effects of IL-1, but regulation of its surface and gene expression remains unknown. We found that occupancy of 2-15% of the IL-1 surface receptor results in dramatic down-regulation of IL-1RtI both at the mRNA and cell surface level in murine D10S cells, a subline of T-helper type 2 cells. At these low occupancy levels (3 x 10(-12) to 3 x 10(-13) M), the reduction in IL-1RtI surface expression appears at 24 hr and continues to 48 and 72 hr. At the mRNA level, low occupancy of the IL-1R results in decreased IL-1RtI mRNA stability; steady state half-life of the IL-1RtI mRNA is reduced from 6 to 1 hr after exposure to 3 x 10(-12) M IL-1. This down-regulation of IL-1RtI by IL-1 is blocked by cycloheximide, suggesting de novo protein synthesis is necessary for decreased RNA stability. Low concentrations of human IL-1 beta, murine and rabbit IL-1 alpha or beta similarly down-regulated IL-1RtI, whereas low concentrations of human IL-1 alpha failed to reduce the receptor surface expression, despite inducing a full proliferative response. We also observed that the effect of IL-1 on this down-regulation was not through protein kinase C (PKC), since PMA rapidly increased IL-1RtI mRNA levels within 30 min and persisted for 24 hr. IL-2 up-regulated IL-1RtI in D10S cells at both mRNA and protein levels. These results demonstrate that low occupancy of IL-1 receptors induces down-regulation of IL-1RtI surface as well as mRNA expression. The regulation of IL-1RtI gene expression may be one of the mechanisms by which IL-1-mediated events are controlled.
Similar articles
-
Interleukin 4 (IL) 4 up-regulates gene and surface IL 1 receptor type I in murine T helper type 2 cells.Eur J Immunol. 1992 Jan;22(1):153-7. doi: 10.1002/eji.1830220123. Eur J Immunol. 1992. PMID: 1530915
-
Induction of urokinase-type plasminogen activator receptor by IL-1 beta.Am J Respir Cell Mol Biol. 1997 Jun;16(6):683-92. doi: 10.1165/ajrcmb.16.6.9191470. Am J Respir Cell Mol Biol. 1997. PMID: 9191470
-
Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.J Immunol. 1998 Apr 1;160(7):3170-9. J Immunol. 1998. PMID: 9531272
-
Interleukin-1 up-regulates transcription of its own receptor in a human fibroblast cell line TIG-1: role of endogenous PGE2 and cAMP.Eur J Immunol. 1992 May;22(5):1221-7. doi: 10.1002/eji.1830220517. Eur J Immunol. 1992. PMID: 1315688
-
The soluble interleukin-2 receptor in haematological disorders.Br J Haematol. 1987 Dec;67(4):377-80. doi: 10.1111/j.1365-2141.1987.tb06156.x. Br J Haematol. 1987. PMID: 3122815 Review. No abstract available.
Cited by
-
Biological response modifiers and infectious diseases: actual and potential therapeutic agents.Int J Antimicrob Agents. 1994;3(4):223-43. doi: 10.1016/0924-8579(94)90050-7. Int J Antimicrob Agents. 1994. PMID: 18611565 Free PMC article.
-
Interleukin 1 modulates growth of human renal carcinoma cells in vitro.Br J Cancer. 1995 Apr;71(4):794-800. doi: 10.1038/bjc.1995.154. Br J Cancer. 1995. PMID: 7710946 Free PMC article.
-
Brain-borne IL-1 adjusts glucoregulation and provides fuel support to astrocytes and neurons in an autocrine/paracrine manner.Mol Psychiatry. 2016 Sep;21(9):1309-20. doi: 10.1038/mp.2015.174. Epub 2015 Dec 8. Mol Psychiatry. 2016. PMID: 26643538
-
Interleukin-1 receptor mRNA expression in activated bovine leukocytes in vitro.Clin Diagn Lab Immunol. 1997 Nov;4(6):769-73. doi: 10.1128/cdli.4.6.769-773.1997. Clin Diagn Lab Immunol. 1997. PMID: 9384305 Free PMC article.
-
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice.Infect Immun. 1994 May;62(5):2065-70. doi: 10.1128/iai.62.5.2065-2070.1994. Infect Immun. 1994. PMID: 8168971 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases